Light a Candle

Lighting a candle has long been a tradition to show hope of a loved one's healing or return as well as to memorialize a loved one who is gone.
At caring.com, you can “light” a virtual candle and create your own personalized pages on the caring website, or show the candle on your own facebook or blog pages. Not only do you raise awareness about an issue you are passionate about, you can also honor or memorialize a loved one.

You must sign up for a free Caring.com account in order to create a Caring Candle. Then, you choose your cause, list the person’s name, the tell his or her story. That’s it – your own page is created. Read some stories here:
http://www.caring.com/caring-candles/candle-spotlight

If you want to put the candle on your page, highlight and copy the code given to you by Caring.com. Then paste the code into the blog or website html editor interface and save it. It works on Blogger, Facebook, TypePad and WordPress.

Besides, the helpful site offers information and support for caregivers regarding legal and medical issues, end of life concerns, housing and home care advice and information.
Over 13,000 candles have been lit. Will you add yours?

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap